Weight Loss

Pill for Weight Loss Acomplia Significantly Reduces Visceral Fat

2007-09-26T08:51:00.000-07:00

A multi center study which was carried out in Japan resulted out that pill for weight loss Acomplia significantly reduces human visceral fat which is the more dangerous kind of abdominal fat. The report of direct evidence of the role of rimonabant in reducing the metabolically active fat was presented at the annual meeting of the European Association for the Study of Diabetes.

Taranabant Nears End of Major Study

2007-09-16T05:39:00.000-07:00

Merck , the rival of Sanofi-Aventis who are the developer of Taranabant are doing a two year study .The study has reached in its final month of the total time with 2,400 paticipants. The approval of diet drug taranabant to the market in the United States is expected in spring 2008. There is no significance of interim results of the trial to scientific meetings. The expectation of approval of

Fat Toddlers Suffering Iron Deficiency

2007-09-04T07:22:00.000-07:00

The first study which pointed out first link between obesity and iron levels in the children ages 1to 3. It is found in the research that the 20 percent of obese toddlers have deficiency of iron which is an alarming high rate. The deficiency of iron can cause anemia as the amount of oxygen carried by the blood through body is reduced. To let toddlers drink cow’s milk and juice containing less

Acomplia diet pill at Indian pharmacies

2007-08-11T03:31:00.000-07:00

Indian media pointed out that copies of acomplia diet pill are being sold at Indian pharmacies .The pill for weight loss can be obatained for as little as $3.60 for a month. In May a half-dozen top respected pharmaceutical companies which includes Ranbaxy and Cipla had received an approval from Indian regulatory authorities to sell their own versions of rimonabant. Acomplia/Zimulti which is

Early sale of Diet pills for weight loss acomplia in United States is a little hope

2007-08-05T08:14:00.000-07:00

In Europe the number of obese and overweight patients who takes diet pills for weight loss acomplia is more than 200,000 . The remaining handful of the patients live in other countries of the world. Sanofi-Aventis didn’t give no significance of approval for early sale in the United States.FDA gives the signal of talking to Sanofi regarding the approval of Zimulti in United States as soon as

Diet pills for weight loss acomplia will be in U.S Market

2007-07-24T08:52:00.000-07:00

Sanofi-Aventis is still hopeful that Acomplia deit pill will be made available in the U.S. market after the approval by the U.S. Food and Drug Administration.The chapter of acomplia in the U.S.market still is not closed for the Sanofi-Aventis.Last month Sanofi pulled its application for the approval of Acomplia Diet Pill in the U.S. market . The FDA had voted against the approval of it by taking

Walking: A Solution For Many Diseases

2007-07-16T09:47:00.000-07:00

There are many exercises and various yoga programs which are enough to confuse any body that which one to adopt to keep your body fit and your health fine. Mayo Physician favors that walking is the one of the best exercise for any of the blood pressure, diabetes, cardiovascular disease, joint problems or mental health problem. The study which was undertaken by physicians from the Shinshu

Diet Drug Acomplia May Reduce Liver Damage

2007-07-12T08:14:00.000-07:00

A new research which was carried out on weight loss diet pill rimonabant by applying to the rat.The study pointed out that rimonabant is beneficial to reduce obesity-related liver damage which can result into cirhossis of the liver.The research was done by a team which was led by Mohammed Bensaid of Sanofi-Aventis . Diet pill rimonabant was given orally daily for 8 weeks and it is found that

Diet Drug Acomplia Keep Weight Off With Indefinite Use

2007-07-03T09:18:00.000-07:00

The statement given by the Sanofi-Aventis that if you don’t want to regain the lost weight by the Acomplia you need to take diet drug acomplia for the rest of life can be useful for the user of weight loss diet pill acomplia. Due to shortage of time Sanofi withdrew its application to sell rimonabant in the United States as FDA decision regarding issues raised which are linked to duration of

Sanofi drops proposal to Sell Diet Drug Acomplia (Rimonabant) in United States

2007-06-30T08:04:00.000-07:00

Sanofi-Aventis has dropped its application for approval of diet drug acomplia temporarily in the United States on June 29, 2007. Sanofi-Aventis took this step for temporarily approval of the weight loss diet pill in the United States after rejection of the sale of diet pill in United States by the FDA's expert advisory committee because of rimonabant’s link to risk of depression and

Recommendations about diet drug acomplia in Europe

2007-06-28T07:38:00.000-07:00

Spokesperson for the European Medicines Agency (EMEA) pointed out that the result of review of diet drug Acomplia (rimonabant) will be published as early as June 29th . The European review of Acomplia has come out followed by the FDA’s decision not to sale of diet drug acomplia in the United States. Currently acomplia is available in Europe which was approved by EMEA more than a year ago .

Relation between weight and suffering of heart attack

2007-06-21T09:22:00.000-07:00

In the research which is carried out by the researches from Germany and Switzerland pointed out that the chance of death caused by heart attack is more in patients having normal weight as compared to the patient who is obese or overweight.Dr Heinz Buettner, head of interventional cardiology at Herz-Zentrum, Krozingen, Germany, who led the study, said: "Although there is no doubt that people who

Diet Drug Acomplia (Rimonabant) Users and Reimbursement for German users.

2007-06-20T07:30:00.000-07:00

The obese people from Germany who take weight loss diet pill acomplia to reduce their weight felt unhappy with the news that they will not be compensating by German state health insurers as a Berlin court upheld a German regulatory body’s decision. Now as per the court’s decision the patients from Germany will pay for the acomplia from their own pocket. From June to November of last year diet

Weight Loss Pill Acomplia or Zimulti ?

2007-06-16T21:18:00.000-07:00

After the disaster of June 13, 2007, in the meeting of FDA regarding safety data provided from clinical trial of the diet drug , there is a sad news for U.S citizens because now the diet drug acomplia under the new name Zimulti will not be available for them. FDA will not approve miracle diet drug rimonabant in the United States .The developer of acomplia planned to use the trade name Zimulti

Acomplia safety data to be reviewed

2007-06-14T09:27:00.000-07:00

The suggestion of U.S panel of experts regarding diet drug Acomplia not to be sold in the United States resulted in to a review of safety data Medicines Agency (EMEA) next week EMEA had approved the diet drug acomplia last year in the European Union and til now The diet drug is prescribed to more than 100000 people. However, the FDA briefing June 13th of its

Suicidality:Foucus of FDA Panel Meeting

2007-06-13T09:05:00.000-07:00

The FDA advisory panel meeting which was held on June 13, 2007 focused the incident of suicide attempted during the clinical trial of the diet drug acomplia. The relationship between rimonabant, depression and suicide has become a big concern for them. Dr. Kelly Posner of the New York State Psychiatric Institute said , “The panel that a major challenge in assessing the number of incidents of

Moment of Truth for Acomplia in U.S.

2007-06-11T08:34:00.000-07:00

The next week ahead will be the moments of truth for Acomplia in United States. First time the long awaited, the FDA staff will disclose his views about diet drug rimonabant (Acomplia / Zimulti) on June 12, 2007. The next day on June 13, 2007 Endocrinologic and Metabolic Drug Advisory Committee , a panel of outside experts will reveal the various concerns about Acomplia and its side

Diet Pill Rimonabant (Acomplia / Zimulti) In UAE for Sale

2007-06-06T09:23:00.000-07:00

There is a good news for the abdominally obese patients with cardiometabolic risk factors living in United Arab Emirates that they can get Diet drug rimonabant (Acomplia / Zimulti) easily in their country. First time the weight loss diet pill acomplia has been launched in the Middle East.The diet pill is already available in Europe , Argentina,Brazil and Mexico for sale for a year. In a servey

Diet Pill Acomplia Available in Mexican Border Pharmacies

2007-06-04T09:49:00.000-07:00

Now Weight loss diet pill Acomplia(rimonabant) is available in pharmacies just across the Mexican border which is away from sale in United States of America. The various reports of purchasing of diet pill acomplia are being received from Mexican towns just across the border from California, Arizona, New Mexico and Texas. In Mexico a standard package of 28 pills cost around $117. It is less

Rimonabant (Acomplia / Zimulti) Launched in India

2007-06-02T10:09:00.000-07:00

Slimona (Rimonabant) will be the name of diet drug acomplia/Zimulti/Remonabant in India which is launched by Zydus Cadila, an Indian manufacturer of generic drugs headed by one of the country's richest men.Slimona (Rimonabant) will be used to cure of obesity in India.The weight loss pill is already on the market in European and Latin American countries while it is still awaiting authoritarian

Acomplia's Benefits !

2007-05-26T04:22:00.000-07:00

Acomplia benefits more of the obese people, still it’s useful for smoking community also. Its trial has confirmed that it is an effective way to relinquish smoking. Although it is one of the most effective weight loss pill. Its always advisable to take any pill with the prior consultation of a general

Acomplia : A miraculous weight loss pill

2007-05-20T05:22:00.000-07:00

It’s a good news for all obese people across the world . Now they can loose their weight with the help of an amazing pill. Acomplia is an anorectic anti-obesity drug. It is a CB1 cannabinoid receptor antagonist.It has direct impact on reduction in appetite.This weight loss pill work on the endocannobinoid system which controls appetite and energy consumption.Simultaneously it blocks some

European Police exposed fake sale of weight loss pill Acomplia on Internet

2007-05-13T06:39:00.000-07:00

European police revealed fake sale of weight loss pill acomplia on internet in European countries after conducted a raid on April 24,25 and 26, 2007 which was led by officers from France's Central Brigade for Industrial and Artistic Fraud and the Central Office for the Fight Against Crimes using Technology and Communications. A U.K citizen was seized in France with a single bottle of fake

Disappointing Sale of Acomplia in Europe

2007-05-06T07:29:00.000-07:00

The sale of diet drug rimonabant (Acomplia / Zimulti) during the period of first three months of 2007 were 15 million Euros which was not a satisfactory sale of the expensive weight loss diet pill. European refusal of repayment of insurance affected the sale of the weight loss pill. According to Sanofi more than 130,000 overweight and obese people have consumed the weight loss pill in Europe

Weight loss Drugs

2007-05-04T08:30:00.000-07:00

Today , the problem of obesity is going on increasing in many countries of the world .The number of victims of obesity is also increasing. Obesity brings many negative shades in the life of human beings. The obese people have to suffer from his personality to his confidence level . Obesity make the obse people inferior to the other.Today there are many weight loss pills in the market. Here are

Acomplia Approved for Sale in Brazil

2007-04-26T08:59:00.000-07:00

It is declared by Sanofi-Aventis that diet drug Acomplia has been approved for sale in Latin America’s largest country ,Brazil on April 26, 2007. The diet drug is used as an add-on to diet and exercise for the treatment of obese patients (BMI more than 30) or overweight patients (BMI more than 27) with associated risk factors, such as type 2 diabetes or dyslipidemia. Now the diet drug is

Consume Less Salt

2007-04-24T09:02:00.000-07:00

In united states , it is pointed out in a research that consumption of the salt in less quantity reduce the risk by 25 percent of cardiovascular disease such as stroke, heart attack, as well as lowering blood pressure and reduces the risk of death.Dr. Erfan al-Shammeri, a cardiologist at Babil Hospital in Sana’a said, “Consuming foods high in salt can lead to high blood pressure. This can occur

Child Obesity Rate Increasing

2007-04-19T08:29:00.000-07:00

In Canada , it is found that the childhood obesity is going on increasing. The study published in the American Journal of Public Health stated,"University of Alberta researchers found that up to 65 per cent of Cree preschoolers in northern Quebec communities were overweight or obese."Dr. Noreen Willows, a community nutritionist at the University of Alberta, and her colleagues also studied

Weight-Loss Surgeries May be Funded by Mississippi

2007-04-17T07:41:00.000-07:00

The Senate of the Mississippi said that the obesity rate of the state is highest in the nation and it is assumed that the government is planning to fund to citizens who need weight-loss surgeries to decrease obesity rates.Sen. Steve Holland said, “The idea of funding these surgeries began when the Mississippi House and Senate investigated the State Board of Health and the medical situation in

Obesity can cause sleep apnea

2007-04-14T08:34:00.000-07:00

A study, led by Dr. Peter Hallowell, a University Hospitals bariatric surgeon was carried out in the University Hospital of Clevelannd .In the study it was found that there are nine in every ten patients who are awaiting weight loss surgery are suffering from sleep apnea which is a more percentage. Nineteen percent of 249 patients were diagnosed with obstructive sleep apnea during December 2003

Acomplia(Rimonabant) will be sold as Zimulti in U.S.

2007-04-07T23:24:00.000-07:00

Now it is declared officially that Zimulti will be the name of weight loss pill acomplia in the U.S. market when it will be approved in United States. Sanofi-Aventis ,developer of rimonabant has reserved the name which they will use for the diet drug for sale in United States if FDA approves it. FDA advisory panel will air the pros and cons about rimonabant on June 13th .The FDA advisory

Acomplia (Rimonabant) Approved for Sale in Switzerland

2007-04-05T06:37:00.000-07:00

There is a good news for the obese or overweight patients of Switzerland that the weight loss pill rimonabant(acomplia/zimulti) has been approved for sale in the country on April 3rd 2007.Now it can be possible to make a treatment of obese patients by this with the risk of cardiovascular . Switzerland where acomplia has been approved is not a member of the European Union which is same as EU

Taranabant – The competitor of Rimonabant

2007-04-03T10:01:00.000-07:00

While FDA held up Sanofi’s diet drug Rimonabant(Acomplia/Zimulti),the Merck’s MK-0364(Taranbant) is currently in phase-3 which is as effective for weight loss as rimonabant having some side effects. The interim results of phase-3 trial of Taranabant have not been reported by the Merck.These results could be different from the anecdotal report. In the trial it was found that the weight loss pill

About the Acomplia

2007-03-31T09:39:00.000-07:00

The weight loss pill acomplia is now available in the U.K , Germany and several other countries. This is a great news for the people who are fighting against the problem of obesity across America and the Europeans. In the Europe market it is marketed as Acomplia which is expected to reach in the United State as Zimulti.The clinical trials of the drug resulted in the prescription of this drug by

Introduction

2007-03-30T10:51:00.000-07:00

Hi....This is Ashton. If you are here you will find all the latest news about the weight loss pill acomplia . Acomplia is the recently developed weight loss pill which is very useful to get rid from excess fat of the body.The weight loss pill is very useful for the people suffering from obesity.